Posterior reversible encephalopathy syndrome (PRES) is a rare and severe neurotoxic encephalopathic state characterized by variable neurologic manifestations ranging from headache confusion to seizures, coma, subcortical vasogenic edema on imaging. PRES commonly induced chronic renal failure, hypertension, chemotherapeutic drugs, eclampsia. hypercalcemia uncommon not widely underlined in the li...

OBJECTIVE Posterior reversible encephalopathy syndrome (PRES) is a cliniconeuroradiological disease entity, which is represented by characteristic magnetic resonance imaging (MRI) findings of subcortical/cortical hyperintensity in T2-weighted sequences. It is more often seen in parietaloccipital lobes, and is accompanied by clinical neurological changes. PRES is a rare central nervous system (C...

Background: Posterior reversible encephalopathy syndrome (PRES), is characterized by headache, lethargy, visual complaints and epileptic seizures. Brain imaging findings include abnormalities of the white matter and the grey matter.The diagnosis currently relies on clinical manifestations and typical neuroimaging findings. Different pathophysiological factors can play role in the disease proces...

Objective: A case that developed unilateral posterior reversible encephalopathy syndrome (PRES) after carotid artery stenting (CAS) is reported. Case Presentation: The patient was a 79-year-old man who underwent CAS for symptomatic right internal carotid artery stenosis. Left hemiparesis and unilateral spatial neglect appeared on the day after the procedure. MRI presented findings characteristi...

Posterior reversible encephalopathy (PRES) is a clinico-neuroradiological transient entity with atypical clinical presentation and hyper-intensities in posterior regions of brain on T2 weighted sequence in magnetic resonance imaging. A well-known condition among neuro-radiologists, PRES is still unfamiliar to many intensive care clinicians. Delay in diagnosis may lead to additional morbidity an...

Subarachnoid hemorrhage–associated cerebral vasospasm (CVS) is a devastating condition. Unfortunately, 66% of patients with aneurysmal subarachnoid hemorrhage (SAH) develop moderate to severe angiographic vasospasm. In the management of CVS, the combination of induced hypertension, hypervolemia, and hemodilution (triple-H therapy) is often used. However, induced hypertension can lead to systemi...

BACKGROUND AND PURPOSE The cause of "posterior reversible encephalopathy syndrome" (PRES) is not established. We recently encountered several patients who developed PRES in the setting of severe infection. In this study, we comprehensively reviewed the clinical and imaging features in a large cohort of patients who developed PRES, with particular attention to those with isolated infection, seps...

PRES is a clinicoradiologic entity, combining seizures, blindness, and coma with MR imaging findings of predominantly vasogenic and occasional cytotoxic edema. In this clinical report, we determined the type of edema by using DWI and FLAIR sequences on MR imaging as well as ADC maps in 28 patients with PRES. The neuradiologic findings were correlated with levels of serum albumin, which is a mai...

Posterior reversible leukoencephalopathy syndrome (PRES) is a recently described disorder with typical radiological findings of bilateral grey and white matter abnormalities in the posterior regions of the cerebral hemispheres. It has been described in children in association with some medications, renal disease, autoimmune disease, transplantation, and sepsis. In this report, we discuss an eig...

Posterior reversible encephalopathy syndrome (PRES) was first identified in 1996, and is typically caused by acute hypertension, renal decompensation, fluid retention, and treatment with immunosuppressants. Predisposing conditions include hypertension, eclampsia, autoimmune disease, leukemia, non-Hodgkin lymphoma (NHL), Idiopathic Thrombocytopenic Purpura (ITP), and Thrombotic Thrombocytopenic ...